Editorial: Glycans: Masters of immunity, from cancers to inflammatory disease
Front Immunol
.
2022 Aug 17:13:1002679.
doi: 10.3389/fimmu.2022.1002679.
eCollection 2022.
Authors
Richard Beatson
1
,
Heinz Läubli
2
3
,
Oliver M T Pearce
4
,
Celso A Reis
5
6
7
8
Affiliations
1
Centre for Inflammation and Tissue Repair, Respiratory Medicine, University College London, London, United Kingdom.
2
Laboratory for Cancer Immunotherapy, Department of Biomedicine and Medical Oncology, University Hospitalheinz, Basel, Switzerland.
3
Laboratory for Cancer Immunotherapy, Department of Internal Medicine, University Hospitalheinz, Basel, Switzerland.
4
Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
5
Instituto de Investigação e Inovação em Saú de (i3s), Universidade do Porto, Porto, Portugal.
6
Instituto de Patologia e Imunologia Molecular da Universidade do Porto (IPATIMUP), Porto, Portugal.
7
Instituto de Ciê ncias Biomé dicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal.
8
Faculdade de Medicina da Universidade do Porto (FMUP), Porto, Portugal.
PMID:
36059462
PMCID:
PMC9429974
DOI:
10.3389/fimmu.2022.1002679
No abstract available
Keywords:
cancer; glycans; glycoimmunology; immunity; inflammatory disease.
Publication types
Editorial
MeSH terms
Humans
Neoplasms*
Polysaccharides*
Substances
Polysaccharides
Grants and funding
27947/CRUK_/Cancer Research UK/United Kingdom